Inventors:
Vanda Pharmaceuticals, Inc. - Washington DC, US
John Joseph Feeney - Olney MD, US
Louis William Licamele - Potomac MD, US
Mihael H. Polymeropoulos - Potomac MD, US
Assignee:
Vanda Pharmaceuticals, Inc. - Washington DC
International Classification:
A61K 31/343
Abstract:
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.